Imatinib mesylate for palliative second-line treatment of advanced biliary tract cancer: a bicentric phase II study (Q44993988)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Imatinib mesylate for palliative second-line treatment of advanced biliary tract cancer: a bicentric phase II study
scientific article

    Statements

    Imatinib mesylate for palliative second-line treatment of advanced biliary tract cancer: a bicentric phase II study (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit